{"id":4151,"date":"2014-03-19T13:12:07","date_gmt":"2014-03-19T13:12:07","guid":{"rendered":"\/?p=4151"},"modified":"2014-03-19T13:12:13","modified_gmt":"2014-03-19T13:12:13","slug":"growlife-inc-otcqbphot-grinds-to-a-halt","status":"publish","type":"post","link":"\/articles\/growlife-inc-otcqbphot-grinds-to-a-halt\/","title":{"rendered":"Growlife Inc. (OTCQB:PHOT) Grinds To a Halt"},"content":{"rendered":"

Growlife Inc. (OTCQB:PHOT<\/a>) dropped sharply all the way to $0.6851 yesterday, taken off balance by the latest reviews of its stock. <\/p>\n

Lately PHOT<\/a> had seen much media exposure, and, as a result of the ensuing hype, the ticker had soared. A bold article even went so far as to compare PHOT<\/a> to Apple (NASDAQ:AAPL<\/a>). It is obvious that the two companies are players on different markets, operating on entirely different scales. That being the case, CNNMoney’s “March Stock Mania” pitting them against each other seems simply ridiculous. How does a fledgeling pot-stock company even compare to the commercial giant that is AAPL<\/a>? Does it even remotely make sense to compare the biblical story of David and Goliath to the commercial standing of two modern-day companies? <\/p>\n

In an expected turn of events, some of the more highly regarded stock commenters of the marijuana market refused to give in to the latest pot-craze. Over the course of the last couple of days, PHOT<\/a> has been bombarded with undermining descriptions, such as “overhyped”, “overvalued”, “one of the highest risk” and “most overpriced stocks in the entire market”. It’s true that the company’s market value is currently significantly larger than even the wildest estimations of its near future estimated total of assets and profits, but are such vicious statements really warranted?<\/p>\n

Ultimately, that’s up to the investor to decide. However, it is an undeniable fact that there are currently a bunch of red flags surrounding PHOT<\/a>. The company’s latest 10-Q, for instance, contained more than a few of them:<\/p>\n